What is Xeomin®?
Xeomin® is approved for the temporary improvement in the appearance of glabellar lines in 14 countries in the European Union (EU), including Germany, the United Kingdom, France, Italy and Spain, under the brand name Bocouture®.
Xeomin® is now also approved by the United States Food and Drug Administration as of July 2011, for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.
For more information on Xeomin®, schedule an appointment online or contact Dr. Mogler directly by calling (702) 219-7778.
Note from Dr. Mogler: All procedures performed under local anesthesia. Results vary from patient to patient. Contact me for a free consultation.
